{"created":"2024-03-25T07:23:37.144969+00:00","id":2000221,"links":{},"metadata":{"_buckets":{"deposit":"366118ad-5b1e-4da6-ad58-90d11ce151ff"},"_deposit":{"created_by":14,"id":"2000221","owner":"14","owners":[14],"pid":{"revision_id":0,"type":"depid","value":"2000221"},"status":"published"},"_oai":{"id":"oai:dmu.repo.nii.ac.jp:02000221","sets":["8:1710732483666"]},"author_link":[],"control_number":"2000221","item_10006_date_granted_11":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2023-03-03"}]},"item_10006_degree_grantor_9":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"ja","subitem_degreegrantor_name":"獨協医科大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"32203","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_10006_degree_name_8":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士（医学）","subitem_degreename_language":"en"}]},"item_10006_description_10":{"attribute_name":"学位授与年度","attribute_value_mlt":[{"subitem_description":"令和4年度","subitem_description_language":"ja","subitem_description_type":"Other"}]},"item_10006_dissertation_number_12":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"甲第845号"}]},"item_10006_relation_15":{"attribute_name":"関連サイト","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1097/FTD.0000000000000843","subitem_relation_type_select":"DOI"}}]},"item_10006_rights_13":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"This is a pre-copyedited, author-produced version of an article accepted for publication in Therapeutic Drug Monitoring . The published version of record Tasaki, Minami MD*; Yasui-Furukori, Norio MD, PhD*,†; Kubo, Kazuyoshi MD, PhD†; Yokoyama, Saaya MD*; Shinozaki, Masataka MD, PhD*; Sugawara, Norio MD, PhD*; Inoue, Yoshimasa BSc*; Shimoda, Kazutaka MD, PhD*. Relationship of Prolactin Concentrations to Steady-State Plasma Concentrations of Aripiprazole in Patients With Schizophrenia. Therapeutic Drug Monitoring 43(4):p 589-592, August 2021. is available online at: https://doi.org/10.1097/FTD.0000000000000843.","subitem_rights_language":"en"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"田﨑, みなみ","creatorNameLang":"en"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2024-03-25"}],"filename":"32203-K845-S.pdf","filesize":[{"value":"754 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"32203-K845-主論文要旨および審査結果の要旨","url":"https://dmu.repo.nii.ac.jp/record/2000221/files/32203-K845-S.pdf"},"version_id":"3344612b-612a-4f76-8585-bcc59d5926f4"},{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2024-03-25"}],"filename":"32203-K845-A.pdf","filesize":[{"value":"616 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"label":"32203-K845-本文","objectType":"fulltext","url":"https://dmu.repo.nii.ac.jp/record/2000221/files/32203-K845-A.pdf"},"version_id":"4f8cdf00-eecf-494f-96e0-0f6c57b9b59d"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_title":"Relationship of prolactin concentrations to steady-state plasma concentrations of aripiprazole in patients with schizophrenia","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Relationship of prolactin concentrations to steady-state plasma concentrations of aripiprazole in patients with schizophrenia","subitem_title_language":"en"}]},"item_type_id":"10006","owner":"14","path":["1710732483666"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2024-03-25"},"publish_date":"2024-03-25","publish_status":"0","recid":"2000221","relation_version_is_last":true,"title":["Relationship of prolactin concentrations to steady-state plasma concentrations of aripiprazole in patients with schizophrenia"],"weko_creator_id":"14","weko_shared_id":-1},"updated":"2024-04-26T05:55:40.221390+00:00"}